# Cisatracurium Besylate

NDC: 0409-1208
Generic name: CISATRACURIUM BESYLATE
Labeler / Manufacturer: Hospira, Inc.
Product type: HUMAN PRESCRIPTION DRUG
Marketing category: Abbreviated NDA (generic)
Dosage form: INJECTION, SOLUTION
Routes: INTRAVENOUS
Marketing started: 20200324

FDA application: ANDA203238

## Active ingredients

- CISATRACURIUM BESYLATE: 2 mg/mL

## Pharmacological class

—

## External sources

- openFDA: https://api.fda.gov/drug/ndc.json?search=product_ndc:"0409-1208"
- FDA NDC Directory: https://www.accessdata.fda.gov/scripts/cder/ndc/dsp_searchresult.cfm?p_ndc=0409-1208
- DailyMed: https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=67908e20-044d-454d-9c51-bf106e817bd0